Nektar Therapeutics
Polymer-sunitinib conjugates
Last updated:
Abstract:
The invention relates to (among other things) polymer-sunitinib conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over sunitinib in unconjugated form.
Status:
Grant
Type:
Utility
Filling date:
7 May 2020
Issue date:
23 Aug 2022